Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Dec. 31, 2025		Dec. 31, 2024
Investments at amortized cost	$ 3,323,282	[1],[2],[3]	$ 3,539,153	[4],[5],[6]
Restricted cash	16,727		22,362
Deferred financing costs	$ 24,411		$ 23,837
Preferred stock, par value	$ 0.01		$ 0.01
Preferred stock, shares authorized	100,000,000		100,000,000
Preferred stock, shares issued	0		0
Preferred stock, shares outstanding	0		0
Common shares, par value	$ 0.01		$ 0.01
Common shares, authorized	400,000,000		400,000,000
Common shares, issued	95,369,400		94,325,686
Common shares, outstanding	94,705,150		93,661,436
Treasury stock, shares	664,250		664,250
Non controlled, Non affiliated Investments
Investments at amortized cost	$ 3,244,762		$ 3,450,644
Controlled, Affiliated Investments
Investments at amortized cost	$ 78,520		$ 88,509

[1] As of December 31, 2025, the estimated cost basis of investments for U.S. federal tax purposes was $3,332,367 resulting in estimated gross unrealized gains and losses of $219,540 and $231,975, respectively.

[2] Certain portfolio company investments are subject to contractual restrictions on sales.

[3] The amortized cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method.

[4] As of December 31, 2024, the estimated cost basis of investments for U.S. federal tax purposes was $3,535,963 resulting in estimated gross unrealized gains and losses of $207,435 and $216,975, respectively.

[5] Certain portfolio company investments are subject to contractual restrictions on sales.

[6] The amortized cost represents the original cost adjusted for the amortization of discounts and premiums, as applicable, on debt investments using the effective interest method.